Prevention of Neointimal Formation After Angioplasty Using Nuclear Factor-&kgr;B Decoy Oligodeoxynucleotide-Coated Balloon Catheter in Rabbit Model

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Circulation. Cardiovascular Interventions

• Publication date

  2014-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCINTERVENTIONS.114.001522PMID 25406205
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Drug eluting balloon versus drug eluting stent in percutaneous coronary interventions: insights from a meta-analysis of 1462 patients.

  2013cited by this paper
• Role of Inflammation and Insulin Resistance in Endothelial Progenitor Cell Dysfunction

  2011cited by this paper
• Oral nuclear factor-κB decoy oligonucleotides delivery system with chitosan modified poly(D,L-lactide-co-glycolide) nanospheres for inflammatory bowel disease.

  2011cited by this paper
• Opposing effects of bim and bcl-2 on lung endothelial cell migration.

  2010cited by this paper
• Physiologically based pharmacokinetic modeling of nanoparticles.

  2010cited by this paper
• The stent-eluting drugs sirolimus and paclitaxel suppress healing of the endothelium by induction of autophagy.

  2009cited by this paper
• Long-Term Clinical Outcomes After Drug-Eluting and Bare-Metal Stenting in Massachusetts

  2008cited by this paper
• Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg.

  2008cited by this paper
• Establishing chitosan coated PLGA nanosphere platform loaded with wide variety of nucleic acid by complexation with cationic compound for gene delivery.

  2008cited by this paper
• Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter

  2008cited by this paper
• Rapid Endothelial Turnover in Atherosclerosis-Prone Areas Coincides With Stem Cell Repair in Apolipoprotein E–Deficient Mice

  2008cited by this paper
• Inhibition of anastomotic intimal hyperplasia using a chimeric decoy strategy against NFkappaB and E2F in a rabbit model.

  2008cited by this paper
• Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter.

  2007cited by this paper
• Drug-Eluting Stent and Coronary Thrombosis: Biological Mechanisms and Clinical Implications

  2007cited by this paper
• Drug-Eluting and Bare Nitinol Stents for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery: Long-Term Results from the SIROCCO Trial

  2006cited by this paper
• Inhibitory effects of NFkappaB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model.

  2006cited by this paper
• Nuclear factor kappaB signaling in atherogenesis.

  2005cited by this paper
• Nuclear Factor &kgr;B Signaling in Atherogenesis

  2005cited by this paper
• Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting Stent: Should We Be Cautious?

  2004cited by this paper
• Rapid endo‐lysosomal escape of poly(DL‐lactide‐coglycolide) nanoparticles: implications for drug and gene delivery

  2002cited by this paper
• NF-κB and cell-cycle regulation: the cyclin connection

  2001cited by this paper
• NF-kappaB and cell-cycle regulation: the cyclin connection.

  2001cited by this paper
• Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency.

  2001cited by this paper
• Hypoxia-induced endothelial apoptosis through nuclear factor-kappaB (NF-kappaB)-mediated bcl-2 suppression: in vivo evidence of the importance of NF-kappaB in endothelial cell regulation.

  2000cited by this paper
• Hypoxia-Induced Endothelial Apoptosis Through Nuclear Factor-κB (NF-κB)–Mediated bcl-2 Suppression In Vivo Evidence of the Importance of NF-κB in Endothelial Cell Regulation

  2000cited by this paper
• Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression.

  1999cited by this paper
• Application of transcription factor "decoy" strategy as means of gene therapy and study of gene expression in cardiovascular disease.

  1998cited by this paper
• In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction

  1997cited by this paper
• The Nuclear Factor κ-B Signaling Pathway Participates in Dysregulation of Vascular Smooth Muscle Cells in Vitroand in Human Atherosclerosis*

  1997cited by this paper
• Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.

  1996cited by this paper
• Vascular injury, repair, and restenosis after percutaneous transluminal angioplasty in the atherosclerotic rabbit.

  1995cited by this paper
• Pathobiology of intimal hyperplasia

  1994cited by this paper
• Migration of Smooth Muscle and Endothelial Cells: Critical Events in Restenosis

  1992cited by this paper

• Next-Generation Drug Delivery Systems and Drugs for Vascular Intervention

  2026cites this paper
• Systematic Review of Interleukin-35 in Endothelial Dysfunction: A New Target for Therapeutic Intervention

  2025cites this paper
• Methotrexate Therapy Promotes Cell Coverage and Stability in in-Stent Neointima

  2021cites this paper
• Decoy Technology as a Promising Therapeutic Tool for Atherosclerosis

  2021cites this paper
• Interleukin-35 promotes early endothelialization after stent implantation by regulating macrophage activation.

  2019cites this paper
• Molecular Pharmacological Approaches for Treating Abdominal Aortic Aneurysm

  2019cites this paper
• A Novel Bioabsorbable Sheet That Delivers NF-κB Decoy Oligonucleotide Restrains Abdominal Aortic Aneurysm Development in Rats.

  2018cites this paper
• NF-κB Decoy Oligodeoxynucleotide-Coated Balloon Catheter for Arteriovenous Fistula in Hemodialysis

  2018cites this paper
• A Rabbit Model of Durable Transgene Expression in Jugular Vein to Common Carotid Artery Interposition Grafts.

  2018cites this paper
• A review of the coronary applications of the drug coated balloon.

  2017cites this paper
• Suppression of chronic inflammation with engineered nanomaterials delivering nuclear factor κB transcription factor decoy oligodeoxynucleotides

  2017cites this paper
• A new approach to transfect NF-κB decoy oligodeoxynucleotides into the periodontal tissue using the ultrasound-microbubble method

  2017cites this paper
• NF-κB as a Therapeutic Target in Inflammatory-Associated Bone Diseases.

  2017cites this paper
• Activation and inflammation of the venous endothelium in vein graft disease.

  2017cites this paper
• The Rabbit Model of Accelerated Atherosclerosis: A Methodological Perspective of the Iliac Artery Balloon Injury.

  2017cites this paper
• 2017). Activation and inflammation of the venous endothelium in vein graft disease. Atherosclerosis

  year unknowncites this paper